UTI Long Term Advantage Fund Series VII is one of the lower-rated funds in its category with a BullWiser Honest Score of 4.2/10 — below the Growth category median of 4.6/10 across 66 funds. Its 3-year CAGR of 11.9% outperforms the Growth category average of 10.9% by +1.1 percentage points. Note: UTI Long Term Advantage Fund Series VII is a Regular plan, which includes distributor commissions in its expense ratio. The Direct plan variant of this fund offers a lower TER and higher net returns for cost-conscious investors.
Fund Details
Fund Name
UTI Long Term Advantage Fund Series VII
Category
Plan Type
Direct · Growth
Expense Ratio
--
Verdict
❌ Poor
1Y Return
54.0%
3Y CAGR
11.9%
vs Category Average — Growth
3Y CAGR
This fund+1.1% vs category avg
Expense Ratio (lower is better)
TER data not available
Honest Score
This fund-0.4 vs category avg
Category: Growth · 66 Direct-plan funds compared · 0% are High Quality
Frequently Asked Questions
What is the BullWiser Honest Score of UTI Long Term Advantage Fund Series VII?
UTI Long Term Advantage Fund Series VII has a BullWiser Honest Score of 4.2/10 (POOR QUALITY).
The score rates the fund across four pillars: returns quality, expense ratio, risk-adjusted performance (Sharpe ratio & max drawdown), and overall fund quality (AUM, age, consistency).
What is the expense ratio of UTI Long Term Advantage Fund Series VII?
The Total Expense Ratio (TER) of UTI Long Term Advantage Fund Series VII Direct Plan is --.
Choosing the Direct plan saves you the distributor commission baked into Regular plans — typically 0.5–1% per year — which compounds significantly over time.
What are the returns of UTI Long Term Advantage Fund Series VII?
UTI Long Term Advantage Fund Series VII has delivered 54.0% 1-year returns and
11.9% 3-year CAGR. For a full NAV history and comparison with category peers,
use BullWiser's MF Analyser.
Past performance is not a guarantee of future returns.
Is UTI Long Term Advantage Fund Series VII a good investment?
BullWiser rates UTI Long Term Advantage Fund Series VII as POOR QUALITY (Honest Score 4.2/10).
Always match a fund to your own risk profile and investment horizon.
Use the MF Analyser to compare it with peers in the Growth category.
How does Direct Plan differ from Regular Plan for UTI Long Term Advantage Fund Series VII?
The Regular plan of UTI Long Term Advantage Fund Series VII includes a distributor commission of 0.5–1.5% per year built into the expense ratio. Switching to the Direct plan of the same fund eliminates this cost — same fund manager, same portfolio, but a lower TER that compounds significantly over time. Use BullWiser's MF Analyser to calculate your exact savings.
See Full Analysis on BullWiser
NAV chart, holdings, Direct vs Regular savings, Sharpe ratio, and personalised comparison — all free.
Open in MF Analyser →Browse Growth Funds
⚠️ Disclaimer: BullWiser is an independent analysis platform, not a SEBI-registered investment advisor.
Honest Scores and verdicts are algorithmic assessments based on publicly available data.
They are not buy/sell recommendations. Please consult a financial advisor before investing.
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully.